IDENTIFICATION OF ANTIPSYCHOTIC DRUG RESPONSE PHENOTYPES BY CLUSTERING LONGITUDINAL DATA: A CRITICAL STEP FOR PERSONALIZED MEDICINE

被引：0
|
作者：
Mas, S. [1 ,2 ,3 ]
Boloc, D. [4 ]
Torres, T. [1 ]
Martinez, A. [1 ]
Rodriguez, N. [1 ]
Parellada, M. [3 ,5 ]
Saiz-Ruiz, J. [3 ,6 ]
Cuesta, M. J. [3 ,7 ]
Gasso, P. [1 ]
Bernardo, M. [2 ,3 ,8 ]
Lafuente, A. [1 ,2 ,3 ]
机构：
[1] Univ Barcelona, Dept Med, Barcelona, Spain
[2] August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain
[3] Carlos III Hlth Inst, Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain
[4] Univ Barcelona, Pharmacol Unit, Dept Clin Fdn, Barcelona, Spain
[5] Univ Complutense, IiSGM, Child & Adolescent Psychiat Dept, Hosp Gen Univ Gregorio Maranon,Sch Med, Madrid, Spain
[6] Univ Alcala, IRYCIS, Hosp Ramon y Cajal, Madrid, Spain
[7] Complejo Hospitalario Navarra, Inst Invest Sanitaria Navarra IdiSNA, Dept Psychiat, Pamplona, Spain
[8] Hosp Clin Barcelona, Barcelona Clin Schizophrenia Unit, Barcelona, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2018年 / 123卷
关键词：
pharmacogenetics; personalized medicine; antipsychotics; clustering;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P157
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [21] Impact of the Microbiome on Statin on-target Response and Side Effects A Step closer to personalized Medicine
    Chakaroun, Rima
    DIABETOLOGIE, 2022, 18 (06): : 749 - 751
  • [22] Predictive biomarkers of therapeutic response in Inflammatory Bowel Disease: a step towards personalized medicine.
    Baldan-Martin, M.
    Azkargorta, M.
    Aransay, A. M.
    Gil-Redondo, R.
    Moreno-Indias, I.
    Iloro, I.
    Soleto, I.
    Orejudo, M.
    Ramirez, C.
    Lucendo, A. J.
    Rodriguez Gutierrez, C.
    Gutierrez, A.
    Martin Arranz, E.
    Bujanda, L.
    Rodriguez-Lago, I.
    Riestra, S.
    Iglesias-Flores, E.
    Bermejo, F.
    Van Domselaar, M.
    Garcia, M. J.
    Fernandez-Salazar, L.
    Garcia-Alonso, J. F.
    Calvet, X.
    Torrealba, L.
    Baston Rey, I.
    Pallares, H.
    Ber, Y.
    Carnerero, E. L.
    Casanova, M. J.
    Millet, O.
    Elortza, F.
    Mato, J. M.
    Tinahones, F. J.
    Chaparro, M.
    Gisbert, J. P.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I114 - I116
  • [23] SERUM DRUG LEVEL AND ANTI-CITRULLINATED PEPTIDE ANTIBODIES AS BIOMARKERS THAT PREDICT EULAR RESPONSE IN RHEUMATOID ARTHRITIS - A NEW STEP TO PERSONALIZED MEDICINE
    Opris, D.
    Diana, M.
    Gainaru, C.
    Iliuta, M.
    Groseanu, L.
    Saulescu, I.
    Constantinescu, C.
    Bojinca, V.
    Balanescu, A.
    Predeteanu, D.
    Ionescu, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 946 - 947
  • [24] Predictive Models of Therapeutic Response to Vedolizumab: A Novel Step into Personalized Medicine in Crohn's Disease?
    Veyrard, Pauline
    Boschetti, Gilles
    Nancey, Stephane
    Roblin, Xavier
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (06) : 1193 - 1195
  • [25] Pharmacogenomic characterization of gemcitabine response - a framework for data integration to enable personalized medicine
    Harris, Michael
    Bhuvaneshwar, Krithika
    Natarajan, Thanemozhi
    Sheahan, Laura
    Wang, Difei
    Tadesse, Mahlet G.
    Shoulson, Ira
    Filice, Ross
    Steadman, Kenneth
    Pishvaian, Michael J.
    Madhavan, Subha
    Deeken, John
    PHARMACOGENETICS AND GENOMICS, 2014, 24 (02): : 81 - 93
  • [26] Large-scale pharmacogenomic studies and drug response prediction for personalized cancer medicine
    Feng, Fangyoumin
    Shen, Bihan
    Mou, Xiaoqin
    Li, Yixue
    Li, Hong
    JOURNAL OF GENETICS AND GENOMICS, 2021, 48 (07) : 540 - 551
  • [27] Large-scale pharmacogenomic studies and drug response prediction for personalized cancer medicine
    Fangyoumin Feng
    Bihan Shen
    Xiaoqin Mou
    Yixue Li
    Hong Li
    Journal of Genetics and Genomics, 2021, 48 (07) : 540 - 551
  • [28] Discovery of a low order drug-cell response surface for applications in personalized medicine
    Ding, Xianting
    Liu, Wenjia
    Weiss, Andrea
    Li, Yiyang
    Wong, Ieong
    Griffioen, Arjan W.
    van den Bergh, Hubert
    Xu, Hongquan
    Nowak-Sliwinska, Patrycja
    Ho, Chih-Ming
    PHYSICAL BIOLOGY, 2014, 11 (06)
  • [29] Personalized Medicine for Neuroblastoma: Moving from Static Genotypes to Dynamic Simulations of Drug Response
    Han, Jeremy Z. R.
    Hastings, Jordan E.
    Phimmachanh, Monica
    Fey, Dirk
    Kolch, Walter
    Croucher, David R.
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (05):
  • [30] GENOME AND OMICS DATA WITH RICH DISEASE PHENOTYPES IN BIOBANK JAPAN PROVIDE INSIGHTS INTO DISEASE BIOLOGY AND PERSONALIZED MEDICINE
    Namba, Shinichi
    Okada, Yukinori
    Matsuda, Koichi
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2024, 87 : 44 - 44
12345